Study on the Tolerance and Efficacy of a New Anti Regurgitation Formula

Clinical trial NCT02425423 · COMPLETED

Trial details

NCT number: NCT02425423
Sponsor: United Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Gastroesophageal Reflux

Start date: 2013-06-01
Primary completion: 2014-03-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.